A newly defined risk signature, consisting of three m6A RNA methylation regulators, predicts the prognosis of ovarian cancer

Lili Fan, Ying Lin, Guang Shu, Liuer He, Zhipeng Yan, Rihan Hai, Gang Yin

Aging · 2020 · 46 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

A RNA methylation regulators are vital participants in ovarian cancer pathology; and IGF2BP1, VIRMA, and ZC3H13 mRNA levels are valuable factors for prognosis prediction and treatment strategy development.

References

26